Skip to content
Back to resident companies

BioDevek

Investment areas

  • Biotech / Life Sciences
  • Materials
Founders & Leadership
Gonzalo Munoz
Headquarters
Cambridge, MA

Focused on improving patient outcomes by developing the next generation of hemostatic solutions.

The Tough Tech problem we are solving

Many internal surgeries rely on sutures or staples to close wounds, yet these traditional methods cannot fully prevent complications such as leaks, infections, or impaired healing at the surgical site. Current biomaterial solutions often lack the adaptability and bio-compatibility needed to work effectively across different tissues and clinical conditions. This challenge leaves patients vulnerable to postoperative complications and limits physicians’ ability to tailor healing strategies to specific procedures and tissue environments.

About our solution

BioDevek is advancing a next-generation platform of tissue-responsive biomaterials designed to enhance healing and reduce complications following surgery. These degradable materials can be sprayed or injected directly onto biological tissues, creating customized barriers that protect wounds while promoting healthy recovery. Engineered to degrade at predetermined rates, our materials also enable localized drug delivery—improving clinical outcomes and reducing systemic side effects. By integrating materials science, biology, and medicine, BioDevek is redefining surgical healing through intelligent, adaptable biomaterials built for real-world clinical performance.